Orbimed Advisors LLC sold $4.9M of CRVS
director, owner at Corvus Pharmaceuticals, Inc.. 1,176,332 shares at an average of $4.16, traded Jun 27, 2025, filed Jul 1, 2025.
Score components
- +15RoleDirector
- +25Trade size$4.9M at market
- +5Share of holdings soldSold 14% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000947871-25-000636, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 27, 2025 | XIn-the-money exercise Common Stockindirect: See Footnotes | +1,397,684 | $3.50 | $4.9M | 8,341,338 | Jul 1, 2025 |
| Jun 27, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -1,176,332 | $4.16 | $4.9M | 7,165,006 | Jul 1, 2025 |
| Jun 27, 2025 | XIn-the-money exercise Common Warrants (right to buy)derivativeindirect: See Footnotes | -1,397,684 | $0.00 | $0 | 0 | Jul 1, 2025 |
Related signals
Other insiders at Corvus Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 53Moderate | Corvus Pharmaceuticals, Inc. | Peter A. Thompson director, owner | $4.9M 1,176,332 shares | -14% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.